0.07 - 0.07
0.04 - 0.15
840.0K / 2.59M (Avg.)
-2.33 | -0.03
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.85%
Negative revenue growth while 8095.HK stands at 312.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
38.95%
Gross profit growth under 50% of 8095.HK's 330.99%. Michael Burry would be concerned about a severe competitive disadvantage.
2673.36%
EBIT growth above 1.5x 8095.HK's 10.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
606.39%
Operating income growth above 1.5x 8095.HK's 272.08%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
339.13%
Positive net income growth while 8095.HK is negative. John Neff might see a big relative performance advantage.
341.67%
Positive EPS growth while 8095.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
341.67%
Positive diluted EPS growth while 8095.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.57%
Slight or no buybacks while 8095.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while 8095.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while 8095.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
69.90%
Positive 10Y revenue/share CAGR while 8095.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
22.37%
Positive 5Y CAGR while 8095.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
23.95%
3Y revenue/share CAGR under 50% of 8095.HK's 101.06%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.68%
Negative 10Y net income/share CAGR while 8095.HK is at 231.52%. Joel Greenblatt sees a major red flag in long-term profit erosion.
235.24%
Positive 5Y CAGR while 8095.HK is negative. John Neff might view this as a strong mid-term relative advantage.
240.54%
3Y net income/share CAGR above 1.5x 8095.HK's 15.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 8095.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-100.00%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-100.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.66%
We cut SG&A while 8095.HK invests at 50.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.